14-21570309-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001005465.2(OR10G3):c.436G>A(p.Val146Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000308 in 1,614,084 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005465.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR10G3 | NM_001005465.2 | c.436G>A | p.Val146Met | missense_variant | 2/2 | ENST00000641040.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR10G3 | ENST00000641040.1 | c.436G>A | p.Val146Met | missense_variant | 2/2 | NM_001005465.2 | P1 | ||
OR10G3 | ENST00000641185.1 | c.436G>A | p.Val146Met | missense_variant | 3/3 | P1 | |||
OR10G3 | ENST00000641655.1 | n.292-228G>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000374 AC: 94AN: 251346Hom.: 0 AF XY: 0.000383 AC XY: 52AN XY: 135816
GnomAD4 exome AF: 0.000312 AC: 456AN: 1461890Hom.: 3 Cov.: 62 AF XY: 0.000325 AC XY: 236AN XY: 727246
GnomAD4 genome AF: 0.000269 AC: 41AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 07, 2022 | The c.436G>A (p.V146M) alteration is located in exon 1 (coding exon 1) of the OR10G3 gene. This alteration results from a G to A substitution at nucleotide position 436, causing the valine (V) at amino acid position 146 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at